Awareness of hepatitis C infection among women with and at risk for HIV

Journal of General Internal Medicine

Volumn 22, Issue 12, 2007, Pages 1689-1694

  Cohen, Mardge H ^a,b,c   Grey, Dennis ^d   Cook, Judith A ^d   Anastos, Kathryn ^e   Seaberg, Eric ^f   Augenbraun, Michael ^g   Burian, Pam ^h   Peters, Marion ⁱ   Young, Mary ^j   French, Audrey ^a,b,c  

^a Cook County Bureau of Health Services ^*  (United States)

^b Stroger Hospital   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g SUNY DOWNSTATE MEDICAL CENTER   (United States)

^h AIDS HEALTHCARE FOUNDATION   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Drug use; Hepatitis C; HIV; Race; Therapy; Women

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; COCAINE; DIAMORPHINE; VIRUS ANTIBODY;

ADULT; AFRICAN AMERICAN; ANEMIA; ARTICLE; AWARENESS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG WITHDRAWAL; ETHNICITY; FEMALE; FOLLOW UP; HEPATITIS C; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFORMATION; INTERVENTION STUDY; LEUKOPENIA; LIVER BIOPSY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PATIENT EDUCATION; POVERTY; PRACTICE GUIDELINE; PROBABILITY; PROSPECTIVE STUDY; RISK;

ADULT; AFRICAN AMERICANS; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTHCARE DISPARITIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RISK FACTORS; UNITED STATES;

EID: 36349018813     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0395-x     Document Type: Article

References (32)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705-14.
2. Bini EJ, Currie SL, Shen H, et al. National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection. J Clin Gastroenterol. 2006;40:732-9.
3. Rockstroh JK. Management of hepatitis C/HIV coinfection. Curr Opin Infect Dis. 2006;19:8-13.
4. Backus LI, Boothroyd D, Deyton LR. HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations. AIDS. 2005;19(Suppl 3):13-9.
5. Hall CS, Charlebois ED, Hahn JA, Moss AR, Bangsberg DR. Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med. 2004;19:357-65.
6. Piccolo P, Borg L, Lin A, Melia D, Ho A, Kreek MJ. Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment. J Addict Dis. 2002;21:55-66.
7. Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with HIV: the D.A.D. study. Arch Intern Med. 2006;166:1632-41.
8. Strader DB, Wright T, Thomas DL, Seeff LB. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39:1147-71.
9. Strader DB. Coinfection with HIV and hepatitis C virus in injection drug users and minority populations. Clin Infect Dis. 2005 1;41(Suppl 1):7-13.
10. Tien PC. Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the veterans affairs hepatitis C resource center program and national hepatitis C program office. Am J Gastroenterol. 2005;100:2338-54.
11. Herrine SK, Rossi S, Navarro VJ. Management of patients with chronic hepatitis C infection. Clin Exp Med. 2006;6:20-6.
12. Zucker DM. A case of health disparity: treatment issues in women with hepatitis C. Gastroenterol Nurs. 2006;29:137-41.
13. Nunes D, Saitz R, Libman H, Cheng DM, Vidaver J, Samet JH. Barriers to treatment of hepatitis C in HIV/HCV-co-infected adults with alcohol problems. Alcohol Clin Exp Res. 2006;30:1520-6.
14. Barkan S, Melnick S, Preston-Martin, et al. The Women's Interagency HIV Study (WIHS)-design, methods, sample, cohort characteristics and comparison with reported AIDS cases in US women. Epidemiology. 1998;9:117-25.
15. Augenbraun M, Goedert JJ, Thomas D, Feldman J, Seaberg EC, French AL, et al. Incident hepatitis C virus infection in women with HIV: a report from the women's interagency HIV study. Clin Infect Diseases. 2003:37;1357-64.
16. Cullen W, Kelly Y, Stanley J, Langton D, Bury G. Experience of hepatitis C among current or former heroin users attending general practice. Ir Med J. 2005;98:73-4.
17. Crockett B, Gifford SM. "Eyes Wide Shut": narratives of women living with hepatitis C in Australia. Women Health. 2004;39:117-37.
18. Coulon M, Rey D, Loubiere S, Fuzibet JG, Gastaut JA, Obadia Y. Perception of hepatitis C infection and its management in women infected by HIV following intravenous use of drugs. Presse Med. 2003;32:1642-8.
19. Restrepo A, Johnson TC, Widjaja D, et al. The rate of treatment of chronic hepatitis C in patients co-infected with HIV in an urban medical centre. Clin Exp Med. 2006;6:20-6.
20. Butt AA, Wagener M, Shakil AO, Ahmad J. Reasons for non-treatment of hepatitis C in veterans in care. J Viral Hepat. 2005;12:81-5.
21. Butt AA, Justice AC, Skanderson M, Rigsby M, Good CB, Kwoh CK. Rate and predictors of treatment prescription for hepatitis C. Gut. 2007;56:385-9
22. Cacoub P, Rosenthal E, Halfon P, Sene D, Perronne C, Pol S. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life. J Viral Hepatitis. 2006;13:678-82.
23. Strauss MS, Astone-Twerell J, Munoz-Plaza CE, et al. Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. BMC Health Serv Res. 2007;7:39. Published online 2007 March 8.
24. Kapadia F, Latka MH, Hagan H, et al. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE). J Urban Health. 2007;84(1):99-115, Jan.
25. Nunes D, Saitz R, Libman H, Cheng DM, Vidaver J, Samet JH. Barriers to treatment of hepatitis C in HIV/HCV-co-infected adults with alcohol problems. Alcohol Clin Exp Res. 2006;30:1520-6.
26. Santos SA, Kontorinis N, Dieterich DT. Management of Chronic Hepatitis C Virus in Patients with HIV. Curr Treat Options Gastroenterol. 2005;8:433-441.
27. Brau N. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-co-infected patients in the era of pegylated interferon and ribavirin. Semin Liver Dis. 2005;25:33-51.
28. Rockstroh JK. Management of hepatitis C/HIV coinfection. Curr Opin Infect Dis. 2006;19:8-13.
29. Clanon KA, Johannes Mueller J, Harank M. Integrating treatment for hepatitis C virus infection into an HIV clinic. Clin Infect Dis. 2005;40(Suppl 5):362-6.
30. Knott A, Dieperink E, Willenbring ML, et al. Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. Am J Gastroenterol. 2006;101:2254-62.
31. Backus LI, Boothroyd D, Deyton LR. HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations. AIDS. 2005;19(Suppl 3):13-9.
32. Huckans MS, Blackwell AD, Harms TA, Indest DW, Hauser P. Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infection. AIDS. 2005;19(Suppl 3):106-15.